524636
OXYGENTAPH
Start SIP
Invest Now
Start SIP in OXYGENTAPH
Performance
- Low
- ₹59
- High
- ₹61
- 52 Week Low
- ₹51
- 52 Week High
- ₹134
- Open Price₹60
- Previous Close₹59
- Volume7,532
- 50 DMA₹58.77
- 100 DMA₹63.41
- 200 DMA₹69.68
Investment Returns
- Over 1 Month + 8.87%
- Over 3 Month -9.18%
- Over 6 Month -40.26%
- Over 1 Year -35.65%
Smart Investing Starts Here Start SIP with Oxygenta Pharmaceutical for Steady Growth!
Oxygenta Pharmaceutical Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -12
- PEG Ratio
- 0
- Market Cap Cr
- 217
- P/B Ratio
- -5.9
- Average True Range
- 3.51
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 0.74
- RSI
- 50.96
- MFI
- 64.37
Oxygenta Pharmaceutical Financials
Oxygenta Pharmaceutical Technicals
EMA & SMA
Current Price
₹58.55
+
0.05
(0.09%)
- Bearish Moving Average 11
- Bullish Moving Average 5
- 20 Day
- ₹58.46
- 50 Day
- ₹58.77
- 100 Day
- ₹63.41
- 200 Day
- ₹69.68
Resistance and Support
59.28
- R3 62.30
- R2 61.53
- R1 60.05
- S1 57.80
- S2 57.03
- S3 55.55
Oxygenta Pharmaceutical Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-04 | Quarterly Results | |
| 2025-11-07 | Quarterly Results | |
| 2025-08-14 | Quarterly Results | |
| 2025-05-30 | Audited Results | |
| 2025-02-14 | Quarterly Results |
Oxygenta Pharmaceutical F&O
About Oxygenta Pharmaceutical
- NSE Symbol
- OXYGENTAPH
- BSE Symbol
- 524636
- ISIN
- INE102E01018
Similar Stocks to Oxygenta Pharmaceutical
Oxygenta Pharmaceutical FAQs
Oxygenta Pharmaceutical share price is ₹58 As on 10 February, 2026 | 07:33
The Market Cap of Oxygenta Pharmaceutical is ₹216.5 Cr As on 10 February, 2026 | 07:33
The P/E ratio of Oxygenta Pharmaceutical is -12 As on 10 February, 2026 | 07:33
The PB ratio of Oxygenta Pharmaceutical is -5.9 As on 10 February, 2026 | 07:33
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.